Yerxa Benjamin R insider trades
Yerxa Benjamin R has filed 11 Form 4s with the SEC that we hold, for Opus Genetics, Inc. (IRD) (President, Director) and Clearside Biomedical, Inc. (CLSD) (Director). Across all of them we count 2 purchases worth $20.0K and 2 sales worth $61.2K reported on Form 4. In the last 12 months: 0 purchases ($0) and 2 sales ($61.2K). The largest single trade was a sale of 7,470 shares of Opus Genetics, Inc. worth $39.1K, dated 2026-04-23. The first filing on our record is dated 2022-03-04 and the latest 2026-07-27.
Opus Genetics, Inc. (IRD)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-11-21 | P, purchase reported on Form 4 | 10,000 | $9.8K | 2024-11-25 |
| 2026-04-23 | S, sale reported on Form 4 | 7,470 | $39.1K | 2026-04-27 |
| 2026-07-23 | S, sale reported on Form 4 | 7,429 | $22.1K | 2026-07-27 |
Clearside Biomedical, Inc. (CLSD)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-05-15 | P, purchase reported on Form 4 | 7,813 | $10.2K | 2024-05-15 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1145910) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms